128 related articles for article (PubMed ID: 38629164)
1. Pilot Study on the Impact of Early Subcutaneous Basal Insulin Administration in Diabetic Ketoacidosis.
Murray DS; Gilbert BW; Cox TR
J Intensive Care Med; 2024 Apr; ():8850666241247516. PubMed ID: 38629164
[No Abstract] [Full Text] [Related]
2. Subcutaneous Insulin Versus Traditional Intravenous Insulin Infusion in Treatment of Mild to Moderate Diabetic Ketoacidosis.
Stuhr K; LeeMaster R; Hickman AW; Reachi B; Pace W; Meek C
J Emerg Med; 2023 Sep; 65(3):e221-e228. PubMed ID: 37689412
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Early Insulin Glargine Administration in the Treatment of Pediatric Diabetic Ketoacidosis.
Welter KJ; Marquez JL; Marshik PL; Yao MV; Bickel ES
J Pediatr Pharmacol Ther; 2023; 28(2):149-155. PubMed ID: 37139251
[TBL] [Abstract][Full Text] [Related]
4. Success of Insulin Infusion Transitions in Moderate to Severe Diabetic Ketoacidosis With Transition Anion Gap of Less Than or Equal to 12 mEq/L Versus Greater Than 12 mEq/L.
Fry K; Ryman K; Abdelmonem A; Wang X; Vassaur J; Kataria V
Hosp Pharm; 2024 Jun; 59(3):334-340. PubMed ID: 38764987
[No Abstract] [Full Text] [Related]
5. Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: a pilot study.
Doshi P; Potter AJ; De Los Santos D; Banuelos R; Darger BF; Chathampally Y
Acad Emerg Med; 2015 Jun; 22(6):657-62. PubMed ID: 26013711
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial.
Thammakosol K; Sriphrapradang C
Diabetes Obes Metab; 2023 Mar; 25(3):815-822. PubMed ID: 36479786
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Outcomes Following Hospital-Wide Implementation of a Subcutaneous Insulin Protocol for Diabetic Ketoacidosis.
Rao P; Jiang SF; Kipnis P; Patel DM; Katsnelson S; Madani S; Liu VX
JAMA Netw Open; 2022 Apr; 5(4):e226417. PubMed ID: 35389497
[TBL] [Abstract][Full Text] [Related]
8. ADDRESSING PITFALLS IN MANAGEMENT OF DIABETIC KETOACIDOSIS WITH A STANDARDIZED PROTOCOL.
Karajgikar ND; Manroa P; Acharya R; Codario RA; Reider JA; Donihi AC; Salata RA; Korytkowski MT
Endocr Pract; 2019 May; 25(5):407-412. PubMed ID: 30657360
[No Abstract] [Full Text] [Related]
9. Evaluation of the Two-Bag System in Adult Diabetic Ketoacidosis Patients.
Cho N; Bushell T; Choi M; Moussavi K
J Pharm Pract; 2021 Feb; 34(1):17-22. PubMed ID: 31216923
[TBL] [Abstract][Full Text] [Related]
10. The SQuID protocol (subcutaneous insulin in diabetic ketoacidosis): Impacts on ED operational metrics.
Griffey RT; Schneider RM; Girardi M; Yeary J; McCammon C; Frawley L; Ancona R; Cruz-Bravo P
Acad Emerg Med; 2023 Aug; 30(8):800-808. PubMed ID: 36775281
[TBL] [Abstract][Full Text] [Related]
11. TREATMENT OF DIABETIC KETOACIDOSIS AND THE WEEKEND EFFECT AT AN URBAN TERTIARY-CARE CENTER.
Mazori AY; Larsen D; Qureshi M; Tabatabaie V
Endocr Pract; 2020 Jun; 26(6):634-641. PubMed ID: 32045289
[No Abstract] [Full Text] [Related]
12. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Gonzalez-Padilla DA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011281. PubMed ID: 26798030
[TBL] [Abstract][Full Text] [Related]
13. Acute Management of Diabetic Ketoacidosis in Adults at 3 Teaching Hospitals in Canada: A Multicentre, Retrospective Cohort Study.
Galm BP; Bagshaw SM; Senior PA
Can J Diabetes; 2019 Jul; 43(5):309-315.e2. PubMed ID: 30579737
[TBL] [Abstract][Full Text] [Related]
14. What are we waiting for? A review of early basal insulin therapy in diabetic ketoacidosis management.
Gilbert BW; Murray DS; Cox TR; He J; Wenski AM; Qualls KE
Am J Emerg Med; 2023 Oct; 72():147-150. PubMed ID: 37531711
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
[TBL] [Abstract][Full Text] [Related]
16. Basal insulin for the management of diabetic ketoacidosis.
Barski L; Brandstaetter E; Sagy I; Jotkowitz A
Eur J Intern Med; 2018 Jan; 47():14-16. PubMed ID: 28864157
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Early Administration of Insulin Glargine in the Acute Management of Diabetic Ketoacidosis.
Mohamed A; Ploetz J; Hamarshi MS
Curr Diabetes Rev; 2021; 17(8):e030221191986. PubMed ID: 33655870
[TBL] [Abstract][Full Text] [Related]
18. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.
Umpierrez GE; Cuervo R; Karabell A; Latif K; Freire AX; Kitabchi AE
Diabetes Care; 2004 Aug; 27(8):1873-8. PubMed ID: 15277410
[TBL] [Abstract][Full Text] [Related]
19. Euglycemic Diabetic Ketoacidosis: Experience with 44 Patients and Comparison to Hyperglycemic Diabetic Ketoacidosis.
Sell J; Haas NL; Korley FK; Cranford JA; Bassin BS
West J Emerg Med; 2023 Nov; 24(6):1049-1055. PubMed ID: 38165186
[TBL] [Abstract][Full Text] [Related]
20. Reducing Diabetic Ketoacidosis Intensive Care Unit Admissions Through an Electronic Health Record-Driven, Standardized Care Pathway.
Edholm K; Lappé K; Kukhareva P; Hopkins C; Hatton ND; Gebhart B; Nyman H; Signor E; Davis M; Kawamoto K; Johnson SA
J Healthc Qual; 2020; 42(5):e66-e74. PubMed ID: 31923009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
